MVM laboratorija - Company finances
|
EUR
|
2024
From: 2024-02-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 111,315 | 134,065 |
| Profit before tax | 34,615 | 36,237 |
| Net profit | 34,615 | 34,802 |
| Equity | 34,616 | 52,786 |
| Liabilities | 29,376 | 5,636 |
| Non-current assets | 6,111 | 10,358 |
| Current assets | 57,881 | 48,064 |
| Total assets | 63,992 | 58,422 |
|
Taxes paid
|
||
| STI taxes | 115 | 90 |
|
Financial indicators
|
||
| Revenue change y/y | - | +20.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 54.1% | 59.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 65.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 31.1% | 26.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 31.1% | 27.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.8 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MVM laboratorija - Social security debts
The company had no debts to Sodra
MVM laboratorija - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MVM laboratorija, MB (code 306674090) is a Small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies (EVRK C.32.50.90). In 2025, the latest financial year, the company generated revenue of €134.1K, up 20.4% year on year from €111.3K in 2024. Net profit remained broadly stable at €34.8K in 2025 compared with €34.6K in 2024, while profit margin declined from 31.1% to 26.0% as sales expanded faster than profit. Over the two-year period, the business showed steady revenue growth and continued positive earnings. Balance sheet position improved in 2025: equity increased to €52.8K from €34.6K, liabilities fell to €5.6K from €29.4K, and total assets were €58.4K. The asset base was dominated by short-term assets, at €48.1K, alongside long-term assets of €10.4K. Key ratios indicate efficient use of capital, with ROE at 65.9%, ROA at 59.6%, debt-to-equity at 0.11, equity ratio at 90.3%, and asset turnover at 2.29x. Revenue per employee cannot be assessed because staff data is not provided.